Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dYoPCfbwoceSaKzhlWPI

  ADVERTISEMENT  
November 1, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
 
  ADVERTISEMENT  
Call for Tenders
The Australian Red Cross Blood Service wishes to advise providers of Floor Standing Blood Bag Centrifuges of a call for tender. To receive more details, prospective suppliers should email bloodcentrifugetender@redcrossblood.org.au by 2.00pm AEDT Friday 9 November 2012. All tenders must be received by 2.00pm AEDT Friday 14 December 2012.

  Science & Health 
 
  • CDC: Spread of West Nile outbreak begins to wane
    The CDC reported on Wednesday that the West Nile virus outbreak continues to spread, but the pace seems to be slowing. Researchers reported 166 new cases and four deaths in the last week, down from 199 new cases and 36 deaths the previous week. Reuters (10/31) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Count on us, because patients are counting on you.
Roche is dedicated to continually improving the standard of patient care by offering a comprehensive portfolio of advanced serology and NAT technologies from one supplier. For more information, contact your local Roche Diagnostics representative.

  Emerging Trends 
  • Cleveland Clinic releases list for top innovations for 2013
    The Cleveland Clinic has released its pick for the top 10 medical innovations for 2013 -- advances in technologies and medical practice that the Clinic considers as having a high chance of commercial success or adoption next year. The list includes ex-vivo lung-perfusion techniques that could make more of the organs suitable for donation. The Plain Dealer (Cleveland) (10/31) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • Biogen's hemophilia drug achieves goal in Phase III study
    Biogen Idec said its investigational hemophilia A drug controlled 98% of bleeding episodes with only one or two injections a week during a late-stage trial compared with an average of three to four injections with existing treatments. The company plans to submit the drug for FDA approval before July and to file an application in Europe after a pediatric trial is completed. Reuters (10/31) LinkedInFacebookTwitterEmail this Story
  • British researchers form stem cell company DefiniGEN
    Researchers at the University of Cambridge in the U.K. have formed a company called DefiniGEN to grow human liver cells from skin cells on a commercial scale. The company aims to provide stem cell products to entities involved in drug development and regenerative medicine. The company also has a system called OptiDIFF that has produced libraries of disease-modeled cells for various conditions. Business Weekly (U.K.) (10/31) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

On-line SBB Exam Review Course offered through The George Washington University.
Self-paced preparation for the ASCP SBB certification exam. Application deadlines: February 1, June 1 and September 1. Main exam content categories covered. Includes sample exam questions. Contact course director, William Turcan, at wturcan@gwu.edu for more information.


  Government & Regulatory 
  • Millennium-Seattle's lymphoma drug gets conditional EU approval
    Millennium: The Takeda Oncology Company and Seattle Genetics obtained conditional approval from the European Commission to market Adcetris, or brentuximab vedotin, for adults with relapsed or refractory systemic anaplastic large cell lymphoma, as well as for relapsed or refractory CD30-positive Hodgkin lymphoma patients who have received autologous stem cell transplants or at least two therapies when transplant or chemotherapy aren't appropriate. Seattle Genetics will receive $25 million for each approval. Genetic Engineering & Biotechnology News (10/31) LinkedInFacebookTwitterEmail this Story
  • AHRQ to investigate effect of IT on clinical workflows
    The Agency for Healthcare Research and Quality plans to investigate how health IT can be deployed in clinics to facilitate care coordination without hurting workflow processes. The research will involve six clinics affiliated with Vanderbilt University Medical Center that are in various stages of EHR rollouts and practice redesign efforts. Health Data Management (10/30) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Reminder: Deadline approaching to submit education session proposals for 2013 AABB Annual Meeting
    The deadline is Nov. 16 for individuals to submit education session proposals for the upcoming 2013 AABB Annual Meeting and CTTXPO in Denver. Proposals should be for 90-minute and three-hour programs focused on cellular therapies, patient blood management, leadership management, quality/education, scientific issues and technical/clinical issues. Submit a proposal. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
VP Patient ServicesBlood Centers of the PacificUS - CA - San Francisco
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Quality Source ConsultantBlood Systems, Inc.US - Nationwide
Quality SpecialistBlood Systems, Inc.US - NM - Albuquerque
Immunohematology Reference TechnologistLifeStreamUS - CA - San Bernardino
Blood Bank Laboratory Supervisor (MT/ASCP)United Blood ServicesUS - MT - Billings
Quality SpecialistBlood Systems, Inc.US - TX - Lubbock
Director, Quality (Chicago area)Blood Systems, Inc.US - IL - Chicago
Director, Quality (Seattle area)Blood Systems, Inc.US - WA - Puget Sound
Consultant - Cellular TherapyAABBUS - MD - Bethesda
Help Desk SpecialistAABBUS - MD
Director, Operational Policies and Procedures (Corporate Donor Recruitment)Blood Systems, Inc.US - AZ - Scottsdale
Blood Bank Supervisors - Donor Collections Program & Transfusion ServiceUTMB HealthUS - TX - Galveston
Country Director - AngolaAABBAGO - Nationwide
Staff AccountantAABBUS - MD
Laboratory Manager-Serology LabBaxter Healthcare (BioLife Plasma Services)US - AL - Hoover
Marketing Manager, Cellular TherapiesAABBUS - MD
Click here to view more job listings.

  SmartQuote 
Nature does not equally distribute energy. Some people are born old and tired while others are going strong at 70."
--Dorothy Thompson,
American journalist and radio broadcaster


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information